Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Essex currently holds 759,985 shares of CardioGenics Holdings Inc. (CGNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Essex has been a net buyer of CGNH stock. They have purchased $50.8K and sold $0 worth of shares.
James Essex's most recent insider trade was on Feb 5, 2015, when they purchased 234,302 shares at $0.11 per share.
James Essex serves as Executive at CardioGenics Holdings Inc. (CGNH). They have executed 2 insider transactions totaling $50.8K over their tenure at the company.
James Essex holds the position of Executive at CardioGenics Holdings Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
James Essex has shown a buying trading pattern, with $50.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James Essex was on Feb 5, 2015, when they purchased $25.8K worth of CGNH shares. This transaction involved 234,302 shares at $0.11 per share.
James Essex currently owns 759,985 shares of CardioGenics Holdings Inc. (CGNH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Essex's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Essex has 2 Form 4 filings on record as an insider at CardioGenics Holdings Inc..
Set alerts for James Essex and 40,000+ other insiders.